P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,602.70
68 (1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 24.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 17.72% vs 3.67% in Sep 2025

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2026 is 25.94% vs 7.54% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 26.69% vs 5.46% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 8.33% vs -20.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
382.49
612.59
-230.10
-37.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
382.49
612.59
-230.10
-37.56%
Raw Material Cost
71.69
331.91
-260.22
-78.40%
Purchase of Finished goods
31.44
21.43
10.01
46.71%
(Increase) / Decrease In Stocks
2.44
-52.53
54.97
104.64%
Employee Cost
53.77
53.94
-0.17
-0.32%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.78
121.51
-50.73
-41.75%
Total Expenditure (Excl Depreciation)
230.12
476.26
-246.14
-51.68%
Operating Profit (PBDIT) excl Other Income
152.37
136.33
16.04
11.77%
Other Income
3.89
0.47
3.42
727.66%
Operating Profit (PBDIT)
156.26
136.80
19.46
14.23%
Interest
0.13
14.95
-14.82
-99.13%
Exceptional Items
0.00
-2.04
2.04
100.00%
Gross Profit (PBDT)
156.13
119.81
36.32
30.31%
Depreciation
6.08
30.53
-24.45
-80.09%
Profit Before Tax
150.05
89.27
60.78
68.09%
Tax
38.54
23.52
15.02
63.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
111.51
65.75
45.76
69.60%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
111.51
65.75
45.76
69.60%
Equity Capital
16.60
45.34
-28.74
-63.39%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
67.17
7.25
59.92
826.48%
Diluted Earnings per share
67.18
7.24
59.94
827.90%
Operating Profit Margin (Excl OI)
39.84%
22.25%
0.00
17.59%
Gross Profit Margin
40.82%
19.56%
0.00
21.26%
PAT Margin
29.15%
10.73%
0.00
18.42%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 382.49 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 5.16% vs -1.82% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 17.72% vs 3.67% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 111.51 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 15.98% vs 1.64% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 25.94% vs 7.54% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 152.37 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 52.98% vs -26.54% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 26.69% vs 5.46% in Sep 2025

Quarterly - Interest
Interest 0.13 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -7.14% vs -33.33% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.33% vs -20.00% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.84%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025